	Our case	Tsouni et al. [10]	Zinebi et al. [5]	Rodriguez-Escalera et al. [8]
Age at the presentation	47 years	49 years	60 years	34 years
Underlying inﬂammatory disorder	Crohn’s disease	inﬂammatory disorders	hemorrhagic rectocolitis	rheumatoid arthritis
A-TNF agent used	infliximab	Infliximab/Adalimumab	infliximab	Infliximab
A-TNF onset to neuropathy	6^th injection	19 months	3 months	4^th injection
Treatment	a-TNF stopped	a-TNF stopped +/-intravenous immunoglobulin	reduction of the dose to half	a-TNF stopped
Neuropathy outcome	Recovered at 3 months	3 months	10 months	6 months